IM Cannabis to Report Fourth Quarter and Full Year 2024 Financial Results on Monday, March 31 2025 at 9:00am ET

Rhea-AI Summary

IM Cannabis (CSE: IMCC) (NASDAQ: IMCC), a leading medical cannabis company operating in Israel and Germany, has scheduled its Fourth Quarter and Full Year 2024 financial results announcement for Monday, March 31, 2025, before market opening.

The company will host a zoom web conference at 9:00 AM ET on the same day to discuss the results, which will include a Q&A session for investors. A recording of the call will be made available on the company's investor relations website within 24 hours after the event.

TORONTO and GLIL YAM, Israel, March 20, 2025 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company," "IMCannabis," or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the fourth quarter and full year 2024 ended December 31, 2024, on Monday, March 31, 2025 before the market opens.

The Company will host a zoom web conference on the same day at 9:00a.m. ET to discuss the results, followed by a question-and-answer session for the investment community. Investors are invited to register by clicking here. All relevant information will be sent upon registration.

If you are unable to join us live, a recording of the call will be available on our website at https://investors.imcannabis.com within 24 hours after the call.

Link to register for the zoom call: https://us02web.zoom.us/webinar/register/WN_RJjroBAjSOSRZLqGuM8CCw

About IM Cannabis Corp.

IMC (Nasdaq: IMCC) (CSE: IMCC) is an international cannabis company that provides premium cannabis products to medical patients in Israel and Germany, two of the largest medical cannabis markets. The Company's focus is to achieve sustainable and profitable growth in its highest value markets, Israel and Germany. The Company leverages a transnational ecosystem powered by a unique data-driven approach and a globally sourced product supply chain. With an unwavering commitment to responsible growth and compliance with the strictest regulatory environments, the Company strives to amplify its commercial and brand power to become a global high-quality cannabis player.

The IMC ecosystem operates in Israel through its commercial relationship with Focus Medical Herbs Ltd., which imports and distributes cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of IMC products throughout the entire value chain. In Germany, the IMC ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients.

Logo: https://mma.prnewswire.com/media/1742228/IM_Cannabis_Logo.jpg

Company Contact:
Anna Taranko, Director Investor & Public Relations
IM Cannabis Corp.
+49 157 80554338
a.taranko@imcannabis.de

Oren Shuster, CEO
IM Cannabis Corp.
+972-77-3603504
info@imcannabis.com

View original content:https://www.prnewswire.com/news-releases/im-cannabis-to-report-fourth-quarter-and-full-year-2024-financial-results-on-monday-march-31-2025-at-900am-et-302406874.html

SOURCE IM Cannabis Corp.

FAQ

When will IM Cannabis (IMCC) release its Q4 and Full Year 2024 earnings?

IM Cannabis will release its Q4 and Full Year 2024 earnings on Monday, March 31, 2025, before market opens.

What time is the IMCC earnings call on March 31, 2025?

The earnings call is scheduled for 9:00 AM ET on March 31, 2025 via Zoom.

How can investors access IMCC's Q4 2024 earnings call?

Investors can register for the Zoom webinar through the company's provided registration link.

Where can investors find the recording of IMCC's Q4 2024 earnings call?

The recording will be available on IM Cannabis' investor relations website within 24 hours after the call.